Adamis Pharmaceuticals (ADMP) Announces Tempol Reduces Lung Inflammation in the COVID-19 Challenged Hamster Model

Go back to Adamis Pharmaceuticals (ADMP) Announces Tempol Reduces Lung Inflammation in the COVID-19 Challenged Hamster Model
ADAMIS PHARMA (NASDAQ: ADMP) Delayed: 0.75 -0.01 (1.32%)
Previous Close $0.76    52 Week High $10.98 
Open $0.76    52 Week Low $2.40 
Day High $0.76    P/E N/A 
Day Low $0.71    EPS $-1.22 
Volume 1,005,896